Edwards Lifesciences Corp vs Eli Lilly & Co.
EW vs LLY — side-by-side comparison from reported financials. EW leads 2, LLY leads 9 of 11 comparable metrics.
Edwards Lifesciences Corp
EW · Healthcare
$85.21+1.15%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | EW | LLY |
|---|---|---|
| Price | $85.21 | $1 177.20 |
| Market cap | $49.1B | $1.05T |
| Revenue (TTM) | $6.51B | $79.7B |
| Revenue growth | +4.1% | +31.7% |
| Net margin | 15.4% | 33.5% |
| Free cash flow | $1.43B | $18.2B |
| Net cash (debt) | $3.63B | ($35.2B) |
| 1-year price return | +13.3% | +37.6% |
| P/E | 48.9 | 41.6 |
| P/E vs own history (cheap-side %) | 11% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 10% | 93% |
| Altman Z-score | 11.86 | 7.10 |
| CV checks passed | 9 of 10 | 11 of 10 |
| Employees | 16,000 | 50,000 |
Full résumé-style profiles: EW CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.